# An fMRI Study Of Brain Response In Patients With Fibromyalgia

> **NCT00760474** · PHASE1 · COMPLETED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 27 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** Pregabalin, then placebo
- **DRUG:** Placebo, then pregabalin

## Key facts

- **NCT ID:** NCT00760474
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2021-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00760474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00760474, "An fMRI Study Of Brain Response In Patients With Fibromyalgia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00760474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*